FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988435763> ?p ?o ?g. }

• W1988435763 endingPage "732" @default.
• W1988435763 startingPage "719" @default.
• W1988435763 abstract "Squamous cell carcinoma (SCC) of the head and neck (H&N) remains a clinical challenge due to its high rate of locoregional disease recurrence. The importance of the epidermal growth factor receptor (EGFR) in the development and progression of many solid tumours (including SCC of the H&N) is well understood; increased expression is associated with enhanced tumour invasion, resistance to chemotherapy and decreased patient survival. Several approaches have been developed to achieve EGFR blockade as an anticancer treatment strategy, including an anti-EGFR monoclonal antibody (mAb), IMC-C225, which competetively binds to the extracellular receptor site to prevent binding by natural EGFR ligands (EGF and TGF-α). Preclinical studies evaluating this chimeric mAb in human cancer cell lines in vitro and human tumour xenografts in vivo have demonstrated its potent antitumour activity. The clinical efficacy of IMC-C225 appears to involve multiple anticancer mechanisms, including inhibition of cell cycle progression, induction of apoptosis, anti-angiogenesis, inhibition of metastasis and its ability to enhance the response to chemotherapy and radiation therapy. Phase I studies of IMC-C225 combined with chemotherapy or radiation for SCC of the H&N demonstrate excellent response rates in patients with recurrent or refractory disease. Phase II and III trials examining the efficacy and safety of these combinations are currently underway. To date, IMC-C225 has been well-tolerated, with skin rashes and allergic reactions being the most clinically important adverse events reported. IMC-C225 displays dose-dependent elimination characteristics and a half-life of approximately 7 days. Current recommendations for dosing include a 400 mg/m2 loading dose, followed by weekly infusions of 250 mg/m2." @default.
• W1988435763 created "2016-06-24" @default.
• W1988435763 creator A5008593691 @default.
• W1988435763 creator A5014133933 @default.
• W1988435763 creator A5067386747 @default.
• W1988435763 date "2001-07-01" @default.
• W1988435763 modified "2023-09-27" @default.
• W1988435763 title "IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer" @default.
• W1988435763 cites W141627170 @default.
• W1988435763 cites W1527076593 @default.
• W1988435763 cites W1553385403 @default.
• W1988435763 cites W1570686199 @default.
• W1988435763 cites W1596261235 @default.
• W1988435763 cites W1608647261 @default.
• W1988435763 cites W1796205058 @default.
• W1988435763 cites W1894641937 @default.
• W1988435763 cites W1939364580 @default.
• W1988435763 cites W1964321121 @default.
• W1988435763 cites W1967096085 @default.
• W1988435763 cites W1972004339 @default.
• W1988435763 cites W1983104536 @default.
• W1988435763 cites W1983645568 @default.
• W1988435763 cites W1986488244 @default.
• W1988435763 cites W1989116149 @default.
• W1988435763 cites W1995992733 @default.
• W1988435763 cites W1999585013 @default.
• W1988435763 cites W2005204942 @default.
• W1988435763 cites W2006612434 @default.
• W1988435763 cites W2008803651 @default.
• W1988435763 cites W2012629036 @default.
• W1988435763 cites W2017788990 @default.
• W1988435763 cites W2019995422 @default.
• W1988435763 cites W2020378886 @default.
• W1988435763 cites W2020600496 @default.
• W1988435763 cites W2021568924 @default.
• W1988435763 cites W2021996848 @default.
• W1988435763 cites W2032644364 @default.
• W1988435763 cites W2036363901 @default.
• W1988435763 cites W2038246466 @default.
• W1988435763 cites W2038882649 @default.
• W1988435763 cites W2040505385 @default.
• W1988435763 cites W2047700479 @default.
• W1988435763 cites W2049613194 @default.
• W1988435763 cites W2059972525 @default.
• W1988435763 cites W2062057316 @default.
• W1988435763 cites W2064047613 @default.
• W1988435763 cites W2072218566 @default.
• W1988435763 cites W2084186083 @default.
• W1988435763 cites W2088658971 @default.
• W1988435763 cites W2103174300 @default.
• W1988435763 cites W2122961418 @default.
• W1988435763 cites W2146447599 @default.
• W1988435763 cites W2164188238 @default.
• W1988435763 cites W2169083148 @default.
• W1988435763 cites W2339422318 @default.
• W1988435763 cites W2406213538 @default.
• W1988435763 cites W4255169631 @default.
• W1988435763 doi "https://doi.org/10.1517/14712598.1.4.719" @default.
• W1988435763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11727507" @default.
• W1988435763 hasPublicationYear "2001" @default.
• W1988435763 type Work @default.
• W1988435763 sameAs 1988435763 @default.
• W1988435763 citedByCount "101" @default.
• W1988435763 countsByYear W19884357632012 @default.
• W1988435763 countsByYear W19884357632013 @default.
• W1988435763 countsByYear W19884357632014 @default.
• W1988435763 countsByYear W19884357632015 @default.
• W1988435763 countsByYear W19884357632016 @default.
• W1988435763 countsByYear W19884357632017 @default.
• W1988435763 countsByYear W19884357632018 @default.
• W1988435763 countsByYear W19884357632019 @default.
• W1988435763 countsByYear W19884357632020 @default.
• W1988435763 countsByYear W19884357632021 @default.
• W1988435763 countsByYear W19884357632022 @default.
• W1988435763 crossrefType "journal-article" @default.
• W1988435763 hasAuthorship W1988435763A5008593691 @default.
• W1988435763 hasAuthorship W1988435763A5014133933 @default.
• W1988435763 hasAuthorship W1988435763A5067386747 @default.
• W1988435763 hasConcept C121608353 @default.
• W1988435763 hasConcept C126322002 @default.
• W1988435763 hasConcept C143998085 @default.
• W1988435763 hasConcept C159654299 @default.
• W1988435763 hasConcept C203014093 @default.
• W1988435763 hasConcept C2776530083 @default.
• W1988435763 hasConcept C2776694085 @default.
• W1988435763 hasConcept C2777658100 @default.
• W1988435763 hasConcept C2779013556 @default.
• W1988435763 hasConcept C2779438470 @default.
• W1988435763 hasConcept C2779998722 @default.
• W1988435763 hasConcept C502942594 @default.
• W1988435763 hasConcept C542903549 @default.
• W1988435763 hasConcept C71924100 @default.
• W1988435763 hasConceptScore W1988435763C121608353 @default.
• W1988435763 hasConceptScore W1988435763C126322002 @default.
• W1988435763 hasConceptScore W1988435763C143998085 @default.
• W1988435763 hasConceptScore W1988435763C159654299 @default.
• W1988435763 hasConceptScore W1988435763C203014093 @default.
• W1988435763 hasConceptScore W1988435763C2776530083 @default.

• next